Cronos Group CRON Q2 2026 earnings

“Cronos delivered a record second quarter by organically achieving record net revenue, record gross profit and record Adjusted EBITDA, while also reducing our share count. Cronos Israel delivered its tenth consecutive quarter of record net revenue, continuing to secure PEACE NATURALS® as the leading cannabis brand in the country. Outside of Israel, our international business also delivered a record net revenue quarter, led by momentum in Germany. In Canada, the Spinach® brand continued to gain significant market share, maintaining its #1 position in vapes for the second consecutive quarter and its #1 position in edibles for the eighth consecutive quarter, while also making notable gains in pre-rolls and flower. We're executing with discipline across our strategic priorities and our results reflect it. We remain active under our share repurchase program and continue to believe the repurchases represent an attractive use of capital. Backed by an industry-leading balance sheet and positive cash flow from operations, we are well positioned to invest in our growth strategy while returning capital to shareholders and maintaining optionality to be opportunistic as attractive opportunities arise.”